MCFT News and Press, MasterCraft Boat Holdings Inc. From 10/10/23

2023-10-10 14:00:16 ET Summary Marine Products Corporation is a leading manufacturer of recreational fiberglass powerboats in the sport and fishing boat markets. The company faces challenges such as competition, barriers to purchase, interest rates, and environmental issues. D...

2023-10-02 16:33:30 ET Summary MasterCraft shares have underperformed the small cap Russell 2000 Index, falling over 14% in 2023. The company has gained market share organically and benefits from favorable demographic trends. Despite disappointing guidance for the current fisc...

VONORE, Tenn., Sept. 13, 2023 (GLOBE NEWSWIRE) -- MasterCraft Boat Holdings, Inc. (NASDAQ: MCFT) (the “Company”) today announced that it has issued its 2023 Sustainability Report. The Company recognizes the importance of social and environmental responsibility and global sustainabil...

2023-09-11 08:10:46 ET Summary MasterCraft offers a terrific risk/reward profile over the next few years, even with elevated interest rates or an economic contraction. It has a net cash balance sheet, a largely variable cost structure, excellent margins, and cash flow, and is well...

2023-08-30 12:29:10 ET Shares of MasterCraft Boat Holdings (NASDAQ: MCFT) were down 15% as of 10:22 a.m. ET after the company posted lower sales and a weaker outlook for the near term. Net sales were down 15% versus the year-ago quarter as higher interest rates made it more expe...

2023-08-30 11:25:44 ET More on Consumer Discretionary Select Sector SPDR ETF Macro Headwinds Ahead, Expect Volatility In Consumer Discretionary Select Sector SPDR ETF XLY: Consumer Discretionary Dashboard For August Intel, Elliott Wave, Fibonacci And Wyckoff; How To ...

2023-08-30 10:48:03 ET MasterCraft Boat Holdings, Inc. (MCFT) Q4 2023 Earnings Conference Call August 30, 2023, 08:30 AM ET Company Participants Tim Oxley - Chief Financial Officer Fred Brightbill - Chief Executive Officer and Chairman George Steinbarger - Presid...

2023-08-30 08:24:12 ET Outlook Therapeutics ( OTLK ) -78% . FibroGen ( FGEN ) -23% announces topline results from LELANTOS-2, a phase 3 clinical study of Pamrevlumab. Ambarella ( AMBA ) -20% after Q2 earning release . MasterCraft Boat Holdings (...

2023-08-30 08:07:58 ET More on MasterCraft Boat MasterCraft Is Set To Turbocharge Investor Value MasterCraft: Small-Cap Stock With Strong Growth Potential Seeking Alpha’s Quant Rating on MasterCraft Boat Earnings data for MasterCraft Boat For f...

2023-08-30 07:33:04 ET More on MasterCraft Boat MasterCraft Is Set To Turbocharge Investor Value MasterCraft: Small-Cap Stock With Strong Growth Potential MasterCraft Boat stock sails higher on signal of resilient sales momentum Seeking Alpha’s Quant R...